Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Change in Inventory (2019 - 2025)

Pulmonx (LUNG) has disclosed Change in Inventory for 7 consecutive years, with $1.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Change in Inventory rose 271.31% to $1.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $108000.0, a 108.48% increase, with the full-year FY2024 number at $229000.0, up 124.95% from a year prior.
  • Change in Inventory was $1.0 million for Q3 2025 at Pulmonx, up from -$660000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $2.0 million in Q1 2022 to a low of -$1.3 million in Q4 2023.
  • A 5-year average of $492736.8 and a median of $604000.0 in 2023 define the central range for Change in Inventory.
  • Peak YoY movement for Change in Inventory: plummeted 463.41% in 2024, then skyrocketed 271.31% in 2025.
  • Pulmonx's Change in Inventory stood at $1.5 million in 2021, then crashed by 136.91% to -$536000.0 in 2022, then tumbled by 151.68% to -$1.3 million in 2023, then skyrocketed by 111.34% to $153000.0 in 2024, then soared by 567.32% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Change in Inventory are $1.0 million (Q3 2025), -$660000.0 (Q2 2025), and -$406000.0 (Q1 2025).